Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Clinical trial NCT02239120 · COMPLETED

Trial details

NCT number: NCT02239120
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stroke Secondary Prevention

Start date: 2014-11-27
Primary completion: 2018-08-14
Enrollment: 5390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.